AstraZeneca/ Bristol-Myers Squibb/ Cancer/ News/ R&D/ UK & Europe Soriot commits to AstraZeneca as shares slide Andrew McConaghie AstraZeneca, AZ, immuno-oncology, MYSTIC, Soriot 0 Comment AstraZeneca (AZ) has tried to put a brave face on today’s news that its immunotherapy combination is unlikely to Share X Soriot commits to AstraZeneca as shares slide https://pharmaphorum.com/news/soriot-commits-astrazeneca-shares-slide/
Cancer/ News/ R&D/ UK & Europe Blow for AstraZeneca as cancer combination fails Andrew McConaghie AstraZeneca, MYSTIC 0 Comment After several years of growing expectation, AstraZeneca’s long-awaited MYSTIC immune-oncology trial has failed to show benefit over standard Share X Blow for AstraZeneca as cancer combination fails https://pharmaphorum.com/news/blow-astrazeneca-cancer-combination-fails/
